Terns Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Terns Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Terns Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Terns Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $5.0M | 95k | 52.72 |
| 2025-12-31 | $25k | 618 | 40.40 |
| 2024-03-31 | $117k | 18k | 6.56 |
| 2023-12-31 | $116k | 18k | 6.49 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas